<i>N</i>-(Hydroxyalkyl) Derivatives of <i>tris</i>(1<i>H</i>-indol-3-yl)methylium Salts as Promising Antibacterial Agents: Synthesis and Biological Evaluation

The wide spread of pathogens resistance requires the development of new antimicrobial agents capable of overcoming drug resistance. The main objective of the study is to elucidate the effect of substitutions in <i>tris</i>(1<i>H</i>-indol-3-yl)methylium derivatives on their a...

Full description

Bibliographic Details
Main Authors: Sergey N. Lavrenov, Elena B. Isakova, Alexey A. Panov, Alexander Y. Simonov, Viktor V. Tatarskiy, Alexey S. Trenin
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/13/12/469
_version_ 1797544566115532800
author Sergey N. Lavrenov
Elena B. Isakova
Alexey A. Panov
Alexander Y. Simonov
Viktor V. Tatarskiy
Alexey S. Trenin
author_facet Sergey N. Lavrenov
Elena B. Isakova
Alexey A. Panov
Alexander Y. Simonov
Viktor V. Tatarskiy
Alexey S. Trenin
author_sort Sergey N. Lavrenov
collection DOAJ
description The wide spread of pathogens resistance requires the development of new antimicrobial agents capable of overcoming drug resistance. The main objective of the study is to elucidate the effect of substitutions in <i>tris</i>(1<i>H</i>-indol-3-yl)methylium derivatives on their antibacterial activity and toxicity to human cells. A series of new compounds were synthesized and tested. Their antibacterial activity in vitro was performed on 12 bacterial strains, including drug resistant strains, that were clinical isolates or collection strains. The cytotoxic effect of the compounds was determined using an test with HPF-hTERT (human postnatal fibroblasts, immortalized with hTERT) cells. The activity of the obtained compounds depended on the carbon chain length. Derivatives with C5–C6 chains were more active. The minimum inhibitory concentration (MIC) of the most active compound on Gram-positive bacteria, including MRSA, was 0.5 μg/mL. Compounds with C5–C6 chains also revealed high activity against <i>Staphylococcus epidermidis</i> (1.0 and 0.5 μg/mL, respectively) and moderate activity against Gram-negative bacteria <i>Escherichia coli</i> (8 μg/mL) and <i>Klebsiella pneumonia</i> (2 and 8 μg/mL, respectively). However, they have no activity against <i>Salmonella cholerasuis</i> and <i>Pseudomonas aeruginosa</i>. The most active compounds revealed higher antibacterial activity on MRSA than the reference drug levofloxacin, and their ratio between antibacterial and cytotoxic activity exceeded 10 times. The data obtained provide a basis for further study of this promising group of substances.
first_indexed 2024-03-10T14:02:19Z
format Article
id doaj.art-badb3b80ee774653b183ae99de2d512d
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-10T14:02:19Z
publishDate 2020-12-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-badb3b80ee774653b183ae99de2d512d2023-11-21T01:02:22ZengMDPI AGPharmaceuticals1424-82472020-12-01131246910.3390/ph13120469<i>N</i>-(Hydroxyalkyl) Derivatives of <i>tris</i>(1<i>H</i>-indol-3-yl)methylium Salts as Promising Antibacterial Agents: Synthesis and Biological EvaluationSergey N. Lavrenov0Elena B. Isakova1Alexey A. Panov2Alexander Y. Simonov3Viktor V. Tatarskiy4Alexey S. Trenin5Gause Institute of New Antibiotics, 11 B. Pirogovskaya Street, 119021 Moscow, RussiaGause Institute of New Antibiotics, 11 B. Pirogovskaya Street, 119021 Moscow, RussiaGause Institute of New Antibiotics, 11 B. Pirogovskaya Street, 119021 Moscow, RussiaGause Institute of New Antibiotics, 11 B. Pirogovskaya Street, 119021 Moscow, RussiaN. N. Blokhin Russian Cancer Research Center, 24 Kashirskoe Shosse, 115478 Moscow, RussiaGause Institute of New Antibiotics, 11 B. Pirogovskaya Street, 119021 Moscow, RussiaThe wide spread of pathogens resistance requires the development of new antimicrobial agents capable of overcoming drug resistance. The main objective of the study is to elucidate the effect of substitutions in <i>tris</i>(1<i>H</i>-indol-3-yl)methylium derivatives on their antibacterial activity and toxicity to human cells. A series of new compounds were synthesized and tested. Their antibacterial activity in vitro was performed on 12 bacterial strains, including drug resistant strains, that were clinical isolates or collection strains. The cytotoxic effect of the compounds was determined using an test with HPF-hTERT (human postnatal fibroblasts, immortalized with hTERT) cells. The activity of the obtained compounds depended on the carbon chain length. Derivatives with C5–C6 chains were more active. The minimum inhibitory concentration (MIC) of the most active compound on Gram-positive bacteria, including MRSA, was 0.5 μg/mL. Compounds with C5–C6 chains also revealed high activity against <i>Staphylococcus epidermidis</i> (1.0 and 0.5 μg/mL, respectively) and moderate activity against Gram-negative bacteria <i>Escherichia coli</i> (8 μg/mL) and <i>Klebsiella pneumonia</i> (2 and 8 μg/mL, respectively). However, they have no activity against <i>Salmonella cholerasuis</i> and <i>Pseudomonas aeruginosa</i>. The most active compounds revealed higher antibacterial activity on MRSA than the reference drug levofloxacin, and their ratio between antibacterial and cytotoxic activity exceeded 10 times. The data obtained provide a basis for further study of this promising group of substances.https://www.mdpi.com/1424-8247/13/12/469<i>tris</i>(1<i>H</i>-indol-3-yl)methyliumturbomycinindole derivativesantibacterial actionovercoming of drug resistance
spellingShingle Sergey N. Lavrenov
Elena B. Isakova
Alexey A. Panov
Alexander Y. Simonov
Viktor V. Tatarskiy
Alexey S. Trenin
<i>N</i>-(Hydroxyalkyl) Derivatives of <i>tris</i>(1<i>H</i>-indol-3-yl)methylium Salts as Promising Antibacterial Agents: Synthesis and Biological Evaluation
Pharmaceuticals
<i>tris</i>(1<i>H</i>-indol-3-yl)methylium
turbomycin
indole derivatives
antibacterial action
overcoming of drug resistance
title <i>N</i>-(Hydroxyalkyl) Derivatives of <i>tris</i>(1<i>H</i>-indol-3-yl)methylium Salts as Promising Antibacterial Agents: Synthesis and Biological Evaluation
title_full <i>N</i>-(Hydroxyalkyl) Derivatives of <i>tris</i>(1<i>H</i>-indol-3-yl)methylium Salts as Promising Antibacterial Agents: Synthesis and Biological Evaluation
title_fullStr <i>N</i>-(Hydroxyalkyl) Derivatives of <i>tris</i>(1<i>H</i>-indol-3-yl)methylium Salts as Promising Antibacterial Agents: Synthesis and Biological Evaluation
title_full_unstemmed <i>N</i>-(Hydroxyalkyl) Derivatives of <i>tris</i>(1<i>H</i>-indol-3-yl)methylium Salts as Promising Antibacterial Agents: Synthesis and Biological Evaluation
title_short <i>N</i>-(Hydroxyalkyl) Derivatives of <i>tris</i>(1<i>H</i>-indol-3-yl)methylium Salts as Promising Antibacterial Agents: Synthesis and Biological Evaluation
title_sort i n i hydroxyalkyl derivatives of i tris i 1 i h i indol 3 yl methylium salts as promising antibacterial agents synthesis and biological evaluation
topic <i>tris</i>(1<i>H</i>-indol-3-yl)methylium
turbomycin
indole derivatives
antibacterial action
overcoming of drug resistance
url https://www.mdpi.com/1424-8247/13/12/469
work_keys_str_mv AT sergeynlavrenov inihydroxyalkylderivativesofitrisi1ihiindol3ylmethyliumsaltsaspromisingantibacterialagentssynthesisandbiologicalevaluation
AT elenabisakova inihydroxyalkylderivativesofitrisi1ihiindol3ylmethyliumsaltsaspromisingantibacterialagentssynthesisandbiologicalevaluation
AT alexeyapanov inihydroxyalkylderivativesofitrisi1ihiindol3ylmethyliumsaltsaspromisingantibacterialagentssynthesisandbiologicalevaluation
AT alexanderysimonov inihydroxyalkylderivativesofitrisi1ihiindol3ylmethyliumsaltsaspromisingantibacterialagentssynthesisandbiologicalevaluation
AT viktorvtatarskiy inihydroxyalkylderivativesofitrisi1ihiindol3ylmethyliumsaltsaspromisingantibacterialagentssynthesisandbiologicalevaluation
AT alexeystrenin inihydroxyalkylderivativesofitrisi1ihiindol3ylmethyliumsaltsaspromisingantibacterialagentssynthesisandbiologicalevaluation